Urvi M. Parikh, PhD

Conceptual Schematic

THE THREE MOST SIGNIFICANT QUESTIONS THAT DEFINE YOUR RESEARCH PROGRAM:
What is the frequency and risk of HIV-1 drug resistance in women who acquire HIV-1 infection while using an antiretroviral product for HIV prevention?

What is the potential impact of resistance from pre-exposure prophylaxis (PrEP) on response to subsequent antiretroviral therapy?

How can algorithms for HIV diagnosis be optimized for people on PrEP in sub-Saharan Africa?

FIVE KEYWORDS THAT DESCRIBE YOUR AREAS OF INTEREST:
• HIV Prevention • Pre-Exposure Prophylaxis • HIV Diagnostics • Drug Resistance • Sub-Saharan Africa

TECHNIQUES, MODELS, METHODS, ANALYTIC APPROACHES, ETC:
Endpoint verification of non-subtype B HIV-1 using HIV diagnostic assays
Quantification of HIV-1 viral RNA
Population viral genotyping and low-frequency resistance analysis
Phenotypic analysis of drug resistance from patient-derived recombinant HIV-1
Real-time PCR for Y chromosome detection in female genital tract samples